Nicolas Wehrli has joined Loyens & Loeff ‘s Zurich office as a partner in the corporate and M&A practice group. Wehrli has extensive experience representing clients in complex M&A, private equity
Search Results for: Loyens %26 Loeff
The Legalcommunity Awards Switzerland 2023 took place at the AURA Event Saal in Zürich. The latest Edition brought together he excellence amongst In-House and law firms’ teams and professionals from the Swiss legal community. The
Loyens & Loeff has appointed Christine Hohl (pictured) as local partner effective 1 May. Hohl advises clients in financing transactions including acquisition financings, asset financings, real estate financings, debt issuances and securitisations. Her clients include banks,
Advestra strengthens its ranks with the incorporation of Andreas Hinsen as a new partner of the firm. Hinsen’s practice focuses on domestic and cross-border M&A transactions, cor
Investindustrial, a leading European group in the field of private equity, has signed an agreement through one of its investment vehicles for the entry of QuattroR into the capital of Medical Technology and Devices Group.
Robin Moser becomes Loyens & Loeff‘s fifth Swiss equity partner with effect from 1 January 2023. He joined Loyens & Loeff in 2019 and heads the Litigation and Risk Management department in the Zurich office. The law
Harmen Holtrop and Roderik Beckers were appointed to the Executive Board of Loyens & Loeff on 6 October 2022. They were appointed at the Annual General Meeting in Amsterdam (The Netherlands) and succeed Bram Linnartz and Thierry
Solvias, an independent pharmaceutical testing and manufacturing company, has acquired Netherlands-based Cergentis to bolster its biologics and cell & gene therapy testing capabilities. Cergentis marks Solvias’ second acquisition since partnering with health care investors Water
Wenger Vieli enhances its Zug team with the joining of Jana Bieli (pictuted) as an associate. Bieli has an extensive expertise in m&a, venture capital, private equity and general corporate law. She also
Doetsch Grether, a company specializing in marketing and sales of products in the pharmaceutical, OTC and consumer care sectors, has entered into an agreement with global pharmaceutical company Vifor Pharma for the takeover of two
